ÂÜÀòÂÒÂ×

Cristina Ferraioli is a seasoned professional in the pharmaceutical industry, currently serving as the National Rare Diseases Neuro Ecosystem Lead at UCB since July 2024. Prior to this role, Cristina held various positions at Eisai EMEA as a Sales Manager focusing on neurology and rare diseases from September 2019 to July 2024, and at Sobi - Swedish Orphan Biovitrum AB as National Sales Manager and Regional Sales Manager specializing in rare diseases and haematology from September 2015 to September 2019. Cristina’s experience also includes strategic roles at Biotest Italia, Baxter International Inc., Menarini, and Blockbuster, covering areas such as immunology, hepatitis B, and haemophilia. Academically, Cristina holds a Master's degree in cellular and molecular biology and a Bachelor's degree in biology from Università degli Studi di Napoli Federico II, complemented by a diploma from liceo scientifico arturo labriola in Naples.